New Jersey A249 prohibits pre-approval or precertification of medical tests, procedures, and prescription drugs under health benefits plans.
New Jersey A249 aims to eliminate the requirement for pre-approval or precertification of medical tests, procedures, and prescription drugs covered under health benefits or prescription drug benefits plans. This bill targets health insurers, third party administrators, pharmacy benefits managers, and the State Health Benefits Program and the School Employees’ Health Benefits Program, ensuring that these entities cannot impose pre-approval or precertification requirements.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.